Philipp Reus

Statistics

Publications

Citations

128

H-Index

Active since

2021

Affiliations

Fraunhofer Institute for Translational Medicine and Pharmacology(Current)

Goethe University Frankfurt

University of Kent

University Hospital Frankfurt

German Center for Infection Research

Philipp Reus is an author at Fraunhofer Institute for Translational Medicine and Pharmacology specializing in sars-cov-2 infection, pharmacology, and medicine.

ORCID

Publications per year

2021–2024

Publications

Targeting the Pentose Phosphate Pathway for SARS-CoV-2 Therapy

Denisa Bojková, Rui Costa, Philipp Reus et al. · Metabolites · 2021 · 51 citations · Full text

Life Sciences, Biochemistry, Pharmacology +17

Ibuprofen, Flurbiprofen, Etoricoxib or Paracetamol Do Not Influence ACE2 Expression and Activity In Vitro or in Mice and Do Not Exacerbate In-Vitro SARS-CoV-2 Infection

Natasja de Bruin, Ann‐Kathrin Schneider, Philipp Reus et al. · International Journal of Molecular Sciences · 2022 · 21 citations · Full text

Medicine, Infectious Diseases, Pharmacology +14

Identification of novel antiviral drug candidates using an optimized SARS-CoV-2 phenotypic screening platform

Denisa Bojková, Philipp Reus, Leona Panosch et al. · iScience · 2023 · 21 citations · Full text

Medicine, Pharmacology, Drug Discovery +14

Drug repurposing for the treatment of COVID-19: Targeting nafamostat to the lungs by a liposomal delivery system

Philipp Reus, Hadar Guthmann, Nadja Uhlig et al. · Journal of Controlled Release · 2023 · 13 citations · Full text

Pharmacy, Pharmaceutics, Pharmacology +17

Characterization of ACE Inhibitors and AT1R Antagonists with Regard to Their Effect on ACE2 Expression and Infection with SARS-CoV-2 Using a Caco-2 Cell Model

Philipp Reus, Ann‐Kathrin Schneider, Thomas Ulshöfer et al. · Life · 2021 · 11 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +14

1–5 of 6